Related Experiment Video

Updated: Jun 18, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Current Status and Future Trends in Myocarditis Related to the COVID-19 Vaccines: A Visual and Bibliometric Analysis

Youao Zhang1, Mengjia Wang1, Jieyan Wang2

  • 1The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.

Current Vascular Pharmacology
|January 21, 2025
PubMed

Insights

This bibliometric analysis reveals a significant increase in research on myocarditis following coronavirus disease 2019 (COVID-19) vaccination. Key areas include vaccine types, safety, and addressing vaccine hesitancy.

Area of Science:

  • Cardiology and Infectious Diseases
  • Vaccinology and Public Health
  • Bibliometrics and Scientometrics

Background:

  • The COVID-19 pandemic has led to extensive research in vaccination and associated adverse events.
  • Myocarditis following COVID-19 vaccination is a growing area of scientific inquiry.
  • There is a substantial increase in studies focusing on the relationship between COVID-19 vaccines and myocarditis.

Purpose of the Study:

  • To perform a bibliometric and visual analysis of research on myocarditis and COVID-19 vaccines.
  • To identify current trends, research hotspots, and emerging frontiers in this field.
  • To provide a comprehensive overview of the global research landscape.

Main Methods:

  • Utilized the Web of Science Core Collection SCI-Expanded database.
  • Employed bibliometric analysis and visualization tools including VOSviewer, Co-Occurrence, Citespace, HistCite, and Scimago Graphica.
  • Analyzed 389 relevant publications.

Main Results:

  • Publication volume shows a consistent upward trend, indicating heightened research interest.
  • The United States is the leading contributor, with Harvard Medical School as a prominent institution.
  • Research hotspots include different COVID-19 vaccine types (mRNA, adenovirus vector, inactivated), vaccine development for reduced incidence, and vaccine hesitancy.
  • Matthew E. Oster is identified as a key author in this research area.

Conclusions:

  • Research on myocarditis and COVID-19 vaccines is rapidly expanding.
  • This study offers insights into the current status and future research directions.
  • Findings can guide researchers in navigating the evolving landscape of vaccine-related myocarditis research.
Abstract

Keywords:
COVID-19 vaccinesbibliometrics.frontiershotspotsmyocarditis

More Related Videos

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy06:38

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Published on: September 26, 2025

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...